DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1Dr. Reddy's Laboratories
02 1NanoAlvand
03 1Baxter Healthcare Corporation
04 1Chia Tai Tianqing Pharmaceutical Group
05 5Eisai
06 5Eisai Inc
07 1Eisai Pharmaceuticals Africa (Pty) Ltd
08 1GLAND PHARMA LIMITED
09 1JIANGXI QINGFENG
10 1Long Grove Pharmaceuticals
11 1Natco Pharma (Canada) Inc
Reset all filters
01 1Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
02 1INJ
03 1Inj Solution
04 1Injection
05 1Injection fluid, resolution
06 2SOLUTION
07 1SOLUTION FOR INJECTION
08 6SOLUTION;INTRAVENOUS
09 1Solution for Injection
10 4Blank
Reset all filters
01 1Lead Market Dossiers- Filed
02 1Originator
03 2Prescription
04 6RX
05 9Blank
Reset all filters
01 5ERIBULIN MESYLATE
02 3HALAVEN
03 8Halaven
04 1NAT-ERIBULIN
05 1Nibulin®
06 1Blank
Reset all filters
01 4Australia
02 2Canada
03 1India
04 1Iran
05 1Italy
06 1Norway
07 1South Africa
08 1Sweden
09 1Switzerland
10 6USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info :
Registration Country : Iran
Brand Name : Nibulin®
Dosage Form : Solution for Injection
Dosage Strength : 1MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-10-01
Application Number : 217250
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2025-03-04
Application Number : 218743
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Switzerland
Brand Name : Halaven
Dosage Form : Inj Solution
Dosage Strength : 1mg/2ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Halaven
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : RX
Registration Country : USA
Brand Name : HALAVEN
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2010-11-15
Application Number : 201532
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : HALAVEN
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 0.44 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Halaven
Dosage Form : Eribulina 0.88Mg 2Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 0.88 mg 2 ml 0.44 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Halaven
Dosage Form : Injection fluid, resolution
Dosage Strength : 0.44 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : HALAVEN
Dosage Form : SOLUTION
Dosage Strength : 0.5MG/ML
Packaging : 2ML
Approval Date :
Application Number : 2377438
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-04-05
Application Number : 218047
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-07-18
Application Number : 214850
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : NAT-ERIBULIN
Dosage Form : SOLUTION
Dosage Strength : 0.5MG/ML
Packaging :
Approval Date :
Application Number : 2539136
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : ERIBULIN MESYLATE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1MG/2ML (0.5MG/ML)
Packaging :
Approval Date : 2024-06-28
Application Number : 218281
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Halaven
Dosage Form : INJ
Dosage Strength : 10mg
Packaging : 2X1mg/2ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF